New York · 2025 Regular Session · Bill
S 9172: Relates to direct access laboratory testing for certain lipid screening assays
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 9172 is a bill introduced in the New York Senate on February 10, 2026. According to its official title, it concerns: Relates to direct access laboratory testing for certain lipid screening assays. Primary sponsor: Pat Fahy (Democratic). Most recent recorded action (February 10, 2026): REFERRED TO HEALTH.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Provides that clinical laboratories may provide laboratory testing at the request of individuals, without a practitioner order or prescription, for certain types of cholesterol.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Pat Fahy | Primary sponsor | Democratic | Senate | 46 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HEALTH